Achivement of target BP level at the background of treatment was noted in 401 patients ( 70.35 % ) including 171 ( 30 % ) patients on monotherapy with FAAC and 230 ( 40,35 % ) patients on combination therapy with FAAC and other antihypertensive drug .
